ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,887Medicare Part D Prescriptions Filled, Including Refills

Rank: 312 out of 680

$405K Total Retail Price of All Prescriptions

Rank: 344 out of 680

348 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 348 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

14% of this provider’s 348 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 7,146 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 339 320 1 2
AMLODIPINE BESYLATE 300 294 2 1
LISINOPRIL 263 263 3 5
LOVASTATIN 249 249 4 44
OMEPRAZOLE 236 218 5 7
ATENOLOL 220 199 6 19
GABAPENTIN 207 194 7 15
HYDROCHLOROTHIAZIDE 196 184 8 9
PRAVASTATIN SODIUM 185 163 9 10
METOPROLOL SUCCINATE 179 174 10 13
ATORVASTATIN CALCIUM 179 154 10 11
FUROSEMIDE 175 158 12 6
ALENDRONATE SODIUM 156 138 13 32
HYDROCODONE-ACETAMINOPHEN 155 125 S3 14 4
SIMVASTATIN 152 124 15 3
METOPROLOL TARTRATE 149 139 16 12
NEXIUM 141 127 17 16
POTASSIUM CHLORIDE 126 98 18 14
SERTRALINE HCL 104 90 19 28
TRAMADOL HCL 98 84 20 18
DIOVAN 96 92 21 31
SYNTHROID 84 77 22 38
DONEPEZIL HCL 82 82 23 27
CITALOPRAM HBR 79 78 24 22
LOSARTAN POTASSIUM 79 69 24 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 71 26 37
METFORMIN HCL 73 56 27 8
DICLOFENAC SODIUM 71 65 28 162
GLIMEPIRIDE 71 71 28 29
MIRTAZAPINE 68 68 30 78
CRESTOR 67 55 31 25
CLONIDINE HCL 64 64 32 36
CLOPIDOGREL 64 50 32 26
CELEBREX 63 54 34 90
PLAVIX 62 47 35 39
ZOLPIDEM TARTRATE 60 60 36 17
BENAZEPRIL HCL 58 52 37 40
OXYBUTYNIN CHLORIDE ER 53 53 38 143
ATENOLOL-CHLORTHALIDONE 52 46 39 205
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.